Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,657 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 951-975 of 1,000 matching filings.

Per page
25
Current page
39
4

PRIMARY DOCUMENT

Filing date
10 Dec 2014
Reporting date
08 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2014
Reporting date
08 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2014
Reporting date
18 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2014
Reporting date
17 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2014
Reporting date
11 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2014
Reporting date
11 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
05 Nov 2014
Reporting date
05 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Oct 2014
Reporting date
28 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A File 001-35670

FORM 4/A SUBMISSION

Filing date
28 Oct 2014
Reporting date
22 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
24 Oct 2014
Reporting date
22 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Oct 2014
Reporting date
22 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
17 Oct 2014
Reporting date
15 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Oct 2014
Reporting date
13 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
10 Oct 2014
Reporting date
08 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
03 Oct 2014
Reporting date
25 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
03 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
26 Sep 2014
Reporting date
24 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
26 Sep 2014
Reporting date
25 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Sep 2014
Reporting date
24 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Sep 2014
Reporting date
17 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
19 Sep 2014
Reporting date
17 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Sep 2014
Reporting date
16 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
12 Sep 2014
Reporting date
10 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35670

FORM 4 SUBMISSION

Filing date
05 Sep 2014
Reporting date
03 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .